Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sanskar Jain, Sk. Abdul Amin, Nilanjan Adhikari, Tarun Jha & Shovanlal Gayen. (2020) Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study. Journal of Biomolecular Structure and Dynamics 38:1, pages 66-77.
Read now
Read now
Articles from other publishers (12)
Sk. Abdul Amin, Nilanjan Adhikari, Shovanlal Gayen & Tarun Jha. (2018) First Report on the Validated Classification-Based Chemometric Modeling of Human Rhinovirus 3C Protease (HRV 3Cpro) Inhibitors. International Journal of Quantitative Structure-Property Relationships 3:2, pages 1-20.
Crossref
Crossref
Ivaylo N. Minchev, Dantcho L. Danalev, Lyubomir T. Vezenkov, Lyubomira Nikolaeva-Glomb & Angel S. Galabov. (2010) An Original Strategy for Gln Containing Peptide Synthesis Using SPPS and Glu(OH)-1-OAll. International Journal of Peptide Research and Therapeutics 16:4, pages 233-238.
Crossref
Crossref
Isak Im, Eui Seung Lee, Soo Jeong Choi, Ju-Yeon Lee & Yong-Chul Kim. (2009) Structure–activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors. Bioorganic & Medicinal Chemistry Letters 19:13, pages 3632-3636.
Crossref
Crossref
Carlos A Martinez, Daniel R Yazbeck & Junhua Tao. (2004) An efficient enzymatic preparation of rhinovirus protease inhibitor intermediates. Tetrahedron 60:3, pages 759-764.
Crossref
Crossref
Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Theodore O. Johnson, Ye Hua, Hiep T. Luu, Sylvie K. Sakata, Edward L. Brown, Fausto C. Maldonado, Tove Tuntland, Caroline A. Lee, Shella A. Fuhrman, Leora S. Zalman, Amy K. Patick, David A. Matthews, Ellen Y. Wu, Ming Guo, Bennett C. Borer, Naresh K. Nayyar, Terence Moran, Lijian Chen, Paul A. Rejto, Peter W. Rose, Mark C. Guzman, Elena Z. Dovalsantos, Steven Lee, Kevin McGee, Michael Mohajeri, Andreas Liese, Junhua Tao, Maha B. Kosa, Bo Liu, Minerva R. Batugo, Jean-Paul R. Gleeson, Zhen Ping Wu, Jia Liu, James W. Meador & Rose Ann Ferre. (2003) Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing Peptidomimetics. Journal of Medicinal Chemistry 46:21, pages 4572-4585.
Crossref
Crossref
Shu-Hui Chen, Jason Lamar, Frantz Victor, Nancy Snyder, Robert Johnson, Beverly A. Heinz, Mark Wakulchik & Q.May Wang. (2003) Synthesis and evaluation of tripeptidyl α-Ketoamides as human rhinovirus 3C protease inhibitors. Bioorganic & Medicinal Chemistry Letters 13:20, pages 3531-3536.
Crossref
Crossref
Donald J. AbrahamChristopher Tseng & Catherine Laughlin. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
359
455
.
James C. Powers, Juliana L. Asgian, Özlem Doǧan Ekici & Karen Ellis James. (2002) Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases. Chemical Reviews 102:12, pages 4639-4750.
Crossref
Crossref
Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Edward L. Brown, Fausto C. Maldonado, Shella A. Fuhrman, Leora S. Zalman, Tove Tuntland, Caroline A. Lee, Amy K. Patick, David A. Matthews, Thomas F. Hendrickson, Maha B. Kosa, Bo Liu, Minerva R. Batugo, Jean-Paul R. Gleeson, Sylvie K. Sakata, Lijian Chen, Mark C. Guzman, James W. Meador, Rose Ann Ferre & Stephen T. Worland. (2002) Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics. Journal of Medicinal Chemistry 45:8, pages 1607-1623.
Crossref
Crossref
Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Theodore O. Johnson, Edward L. Brown, Fausto C. Maldonado, Shella A. Fuhrman, Leora S. Zalman, Amy K. Patick, David A. Matthews, Xinjun Hou, James W. MeadorIIIIII, Rose Ann Ferre & Stephen T. Worland. (2002) Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. Part 7: Structure–Activity Studies of Bicyclic 2-Pyridone-Containing Peptidomimetics. Bioorganic & Medicinal Chemistry Letters 12:5, pages 733-738.
Crossref
Crossref
Nicholas A Meanwell, John F Kadow & Paul M Scola. 2002. Annual Reports in Medicinal Chemistry Volume 37. Annual Reports in Medicinal Chemistry Volume 37
133
147
.
Sheo B Singh, Pia L Graham, Robert A Reamer & Michael G Cordingley. (2001) Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure–activity relationships of 2-methoxystypandrone and its analogues. Bioorganic & Medicinal Chemistry Letters 11:24, pages 3143-3146.
Crossref
Crossref